Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 4.30M P/E - EPS this Y - Ern Qtrly Grth -
Income -9.02M Forward P/E -0.58 EPS next Y - 50D Avg Chg -22.00%
Sales 8.05M PEG - EPS past 5Y - 200D Avg Chg -73.00%
Dividend N/A Price/Book 0.50 EPS next 5Y - 52W High Chg -96.00%
Recommedations 3.00 Quick Ratio 0.76 Shares Outstanding 506.68K 52W Low Chg 11.00%
Insider Own 459.36% ROA -63.46% Shares Float 466.55K Beta 1.38
Inst Own 81.70% ROE -184.59% Shares Shorted/Prior 9.95K/13.64K Price 1.46
Gross Margin 67.48% Profit Margin -112.11% Avg. Volume 165,370 Target Price -
Oper. Margin -104.53% Earnings Date Nov 6 Volume 63,032 Change 2.82%
About ReShape Lifesciences, Inc.

ReShape Lifesciences Inc. provides products and services that manages and treat obesity and metabolic diseases in the United States, Australia, Europe, and internationally. The company's product portfolio includes Lap-Band System, a minimally invasive long-term treatment of severe obesity and more invasive surgical stapling procedures, such as the gastric bypass or sleeve gastrectomy; Lap-Band 2.0 System, an adjustable postoperatively to increase or decrease the pressure to the band in order to optimize an individual's comfort and therapy effectiveness; and ReShape Calibration Tubes, that fits the lesser curvature of the stomach to reach the pylorus. It is also involved in developing ReShape Obalon Balloon System, consists of a swallowable capsule that tracks and displays the location of the balloon during placement; and ReShape Diabetes Bloc-Stim Neuromodulation (DBSN) device, a technology that is in development for the treatment of type 2 diabetes mellitus. The company was formerly known as EnteroMedics Inc. and changed its name to ReShape Lifesciences Inc. in 2017. ReShape Lifesciences Inc. was incorporated in 2002 and is headquartered in Irvine, California.

ReShape Lifesciences, Inc. News
11/14/24 ReShape Lifesciences® Reports Third Quarter Ended September 30, 2024 Financial Results and Provides Corporate Update
11/12/24 ReShape Lifesciences® to Announce Financial Results for the Third Quarter Ended September 30, 2024, and Provide Corporate Update
11/12/24 ReShape Lifesciences® Receives Health Canada Approval for its Next-Generation Lap-Band® 2.0 FLEX
11/11/24 ReShape Lifesciences® Receives NIH Supplementary Grant with the University of Southern California’s Center for Autonomic Nerve Recording and Stimulation Systems (CARSS) to Further Develop Next-Generation Electrodes for ReShape’s Proprietary Diabetes Bloc-Stim Neuromodulation™ Technology
09/23/24 Upcoming Stock Splits This Week (September 23 to September 27) – Stay Invested
09/19/24 ReShape Lifesciences Announces 1-for-58 Reverse Stock Split
08/14/24 ReShape Lifesciences® Reports Second Quarter Ended June 30, 2024 Financial Results and Provides Corporate Update
08/13/24 ReShape Lifesciences® to Announce Financial Results for the Second Quarter Ended June 30, 2024, and Provide Corporate Update
07/09/24 Vyome to go public and trade on the Nasdaq Capital Market under the ticker symbol “HIND”
07/09/24 ReShape Lifesciences® Enters Into Merger Agreement With Vyome Therapeutics and Asset Purchase Agreement With Biorad Medisys
05/16/24 Reshape Lifesciences Inc (RSLS) Q1 2024 Earnings Call Transcript Highlights: Strategic ...
05/15/24 ReShape Lifesciences® Reports First Quarter Ended March 31, 2024 Financial Results and Provides Corporate Update
05/14/24 ReShape Lifesciences® to Announce Financial Results for the First Quarter Ended March 31, 2024, and Provide Corporate Update
04/03/24 ReShape Lifesciences Full Year 2023 Earnings: EPS Beats Expectations, Revenues Lag
04/01/24 ReShape Lifesciences® Reports Year Ended December 31, 2023 Financial Results and Provides Corporate Update
03/28/24 ReShape Lifesciences® Receives Notice of Allowance for Additional U.S. Patent Related to an Intragastric Balloon System
03/04/24 ReShape Lifesciences® Provides Update on 2024 Cost Reduction Plan and Reorganization to Prioritize Commercialization of Lap-Band® 2.0 FLEX
02/22/24 ReShape Lifesciences® Announces First Surgeries Utilizing Next-Generation Lap-Band® 2.0 FLEX
08:31 AM ReShape Lifesciences® Conducts Bariatric Fellows Training for its Lap-Band® System, Highlighting the Next-Generation Lap-Band® 2.0 FLEX
12/20/23 ReShape Lifesciences® Engages Maxim Group LLC To Identify Strategic M&A Partnership Alternatives
RSLS Chatroom

User Image Qwikkzz Posted - 1 day ago

$RSLS Cannot wait till the hourly action starts crossing that 80mf. I have said that on $PDYN ...once it happens, late chasers will flock in. GOOODDD LUCKKK!!!💪💪💪

User Image SamaraMarkets Posted - 1 day ago

🚨 MYNZ Petra Brand Ambassador says to keep an eye on "BIG NEWS from the NFL." This is going to run parabolic soon, right after the healthcare giant Thermo Fisher ($210B mkt cap) partnered with Mainz to develop and launch together ColoAlert in US 🚀 Buy the dip now, the train is leaving very soon. $RIME $GRI $RSLS

User Image tradingtwenty Posted - 1 day ago

Top 5 stocks by smallest market cap that have trended in the past 24 hours: $WORX 3.45M🔥 $RSLS 3.98M $CEAD 4.73M $VRPX 4.77M $WHLR 5.62M Link: https://tradingtwenty.com/dashboard/trending/past

User Image Clearheaded Posted - 2 days ago

$RSLS

User Image Ck925 Posted - 2 days ago

$RSLS

User Image Bio_Be_Dirty Posted - 2 days ago

$RSLS how many r/s has this crap had, it’s due for a pump though lol. Such garbage

User Image Qwikkzz Posted - 2 days ago

$RSLS Officially traded our of cloud resistance on the hourly 🔥🔥🔥 Goodluck

User Image Qwikkzz Posted - 2 days ago

$RSLS Hourly chart is heating up!!!

User Image tradingtwenty Posted - 4 days ago

Top 5 stocks by smallest market cap that have trended in the past 24 hours: $PRFX 1.19M🔥 $RSLS 2.68M $UAVS 3.31M $SINT 4.27M $ATCH 5.12M Link: https://tradingtwenty.com/dashboard/trending/past

User Image Bibby12 Posted - 4 days ago

$RSLS somebody is up early to sell 1 share on bid at 4.95. But why? Do some shareholders panic and actually sell?

User Image EarlofLondon Posted - 4 days ago

$RSLS market not open to trade yet However look at the potential here $119m shareholders value Mcap $3m currently This not on the radar of many Investors yet! Help yourself before Market opens by DD and research 2000% potential

User Image EarlofLondon Posted - 5 days ago

$NCNC wow fantastic rise Another one on my list $RSLS (huge potential because of merger worth c$137m) Mcap only $3m Keep on the watchlist 👍🏼

User Image Aquablue Posted - 5 days ago

$RSLS Bid/Ask, $4.53 and $5.70.

User Image a1111617 Posted - 5 days ago

$RSLS MUST LISTEN!! Krishna talks about exciting plans and future of Vyome Holdings merger. Listen in from (15:00 min mark) this is a great opportunity for new and existing investors/shareholders. https://ir.reshapelifesciences.com/events-and-presentations

User Image james566 Posted - 5 days ago

$RSLS i'm stuck in this 1, 4 a while.

User Image RealErnFranklin Posted - 1 week ago

This whole < 500k float finviz list , noone buying $ALBT 69k traded $PRTG 10k , 10k !! $RSLS 40k , i mean wtf Ya call urself traders, but ur waiters. And thats cool, but different. $ZONE will get slaps monday, and will trade and we get sells off the runs. And will get over 20k volume for the day. Like over a million. Trade, traders. Jeezis.

User Image Gladney Posted - 1 week ago

$RSLS was there RS again? Must be over 20 RS made here. Pure scam. Do your own dd. Enteromedics , maxim group llc, dying products. Scam after scam.

User Image Bibby12 Posted - 1 week ago

$RSLS where are the retards selling at 4.40-4.60 last night. Right…. fake trades. But why?

User Image Zamasu_ Posted - 1 week ago

$ZONE Watching higher highs $evo had news $rsls financials out

User Image Bibby12 Posted - 1 week ago

$RSLS where are all the $4 trades now? Completely fake trades to scare the minions

User Image Zamasu_ Posted - 1 week ago

$ZONE Watching higher highs $evo had news $rsls financials out

User Image Bibby12 Posted - 1 week ago

$RSLS look at all the fake trades after hours yesterday and pre market today. Guarantee it won’t see those prices during market hours. Who’s doing these scare tactic trades? 1 share, 50 shares….etc

User Image DwtnCBrown Posted - 1 week ago

$ZONE higher highs $evo had news $rsls financials out

User Image FridayGuy Posted - 1 week ago

$RSLS uH OH; What the hell happened here?

User Image Nosecandy_Bear Posted - 1 week ago

$RSLS get this delisted immediately. Pure trash.

User Image Bibby12 Posted - 1 week ago

$RSLS Pursuant to the Asset Purchase Agreement, and subject to the satisfaction or waiver of the conditions specified therein, ReShape will sell substantially all of its assets (excluding cash) to Biorad, and Biorad will assume substantially all of ReShape’s liabilities, for a purchase price of $5.16 million in cash,

User Image Aquablue Posted - 1 week ago

$RSLS From today’s PR: “As of September 30, 2024, the Company had net working capital of approximately $1.3 million, primarily due to cash and cash equivalents and restricted cash of $0.8 million.” Current market cap of around $2.62 million.

User Image Bibby12 Posted - 1 week ago

$RSLS until the merger is a done deal there will be all kinds of fuckery with share price. No doubt in my mind there are naked shorts in this one. Perhaps heavy.

User Image Bibby12 Posted - 1 week ago

$RSLS proper value should be in range of $20-28. Read the filings. Do your DD. Gupta just said merger company should be valued at 130M

User Image Bibby12 Posted - 1 week ago

$RSLS they also should have closer to 5M cash as they are selling assets as merger concludes. So percentage likely higher

Analyst Ratings
Maxim Group Hold Jul 17, 24
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
STANKOVICH THOMAS Chief Financial Offi.. Chief Financial Officer Nov 04 Sell 0.27 8,393 2,266 332,761 11/10/22
STANKOVICH THOMAS Chief Financial Offi.. Chief Financial Officer Aug 05 Sell 0.47 4,728 2,222 351,791 08/11/22
Bandy Barton P. President and CEO President and CEO Aug 05 Sell 0.47 11,674 5,487 773,098 08/11/22
Bandy Barton P. President and CEO President and CEO Jun 01 Sell 0.96 11,309 10,857 796,214 06/06/22
STANKOVICH THOMAS Chief Financial Offi.. Chief Financial Officer May 31 Buy 0.91 20,000 18,200 365,627 06/01/22
STANKOVICH THOMAS Chief Financial Offi.. Chief Financial Officer Apr 01 Sell 1.13 5,038 5,693 350,156 04/08/22
Bandy Barton P. President and CEO President and CEO Jan 04 Sell 1.79 7,150 12,798 844,865 01/28/22
STANKOVICH THOMAS Chief Financial Offi.. Chief Financial Officer Jan 04 Sell 1.78 3,171 5,644 362,536 01/28/22